These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20112472)

  • 1. Radical prostatectomy in the treatment of prostate cancer. The experience of the Urology Clinic of Prof. Dr. Th. Burghele Clinical Hospital.
    Ambert V; Braticevici B; Damian D; Chira I; Iconaru V; Radu T; Constantin T
    J Med Life; 2009; 2(3):279-87. PubMed ID: 20112472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined reporting of cancer control and functional results of radical prostatectomy.
    Salomon L; Saint F; Anastasiadis AG; Sebe P; Chopin D; Abbou CC
    Eur Urol; 2003 Dec; 44(6):656-60. PubMed ID: 14644116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery.
    Suardi N; Moschini M; Gallina A; Gandaglia G; Abdollah F; Capitanio U; Bianchi M; Tutolo M; Passoni N; Salonia A; Hedlund P; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2013 May; 111(5):717-22. PubMed ID: 22726993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
    Walsh PC; Partin AW; Epstein JI
    J Urol; 1994 Nov; 152(5 Pt 2):1831-6. PubMed ID: 7523730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A; Murai M; Baba S; Ogawa O; Tsukamoto T; Niwakawa M; Tobisu K; Kinukawa N; Naito S
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
    Sun M; Abdollah F; Hansen J; Trinh QD; Bianchi M; Tian Z; Briganti A; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    J Sex Med; 2012 Nov; 9(11):2961-9. PubMed ID: 22672479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    Carini M; Masieri L; Minervini A; Lapini A; Serni S
    Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database.
    Vesey SG; McCabe JE; Hounsome L; Fowler S
    BJU Int; 2012 Feb; 109(3):346-54. PubMed ID: 21771246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens.
    Koie T; Mitsuzuka K; Narita S; Yoneyama T; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C
    Scand J Urol; 2015 Apr; 49(2):103-7. PubMed ID: 25165894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
    Salomon L; Droupy S; Yiou R; Soulié M
    Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative erectile function is an independent predictor for decision to spare cavernous nerves during radical prostatectomy.
    Stember DS; Nelson CJ; Mulhall JP
    J Sex Med; 2013 Aug; 10(8):2101-7. PubMed ID: 23679104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.
    Anderson CB; Tin AL; Sjoberg DD; Mulhall JP; Sandhu J; Touijer K; Laudone VP; Eastham JA; Scardino PT; Ehdaie B
    BJU Int; 2016 Jun; 117(6B):E46-51. PubMed ID: 26118438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.